United States
About the product
Promogran Matrix Family has been shown to be effective through multiple Randomized Controlled Trials (RCTs), that have been systematically reviewed in meta-analysis.(1)(2)
Suggested Applications
•Promogran Prisma Matrix, when used without ActiV.A.C. Therapy System, is intended for the management of exuding wounds. Under the supervision of a health care professional, Promogran Prisma Matrix may be used for the management of: Diabetic ulcers, Venous ulcers, Pressure ulcers, Ulcers caused by mixed vascular etiologies, Full thickness and partial thickness wounds, Donor sites and other bleeding surface wounds, Abrasions, Traumatic wounds healing by secondary intention and Dehisced surgical wounds.* *Please refer to Instructions For Use for full application instructionsLegal
1. Gottrup F, Cullen B, Karlsmark T, Bischoff-Mikkelsen M, Nisbet L, Gibson M. Randomized controlled trial on collagen/oxidized regenerated cellulose /silver treatment. Wound Repair & Regeneration 2013; 21: 1-10. 2. Cullen B, Ivans N. Promogran TM & Promogran Prisma TM Made Easy. Wounds International. 2010;1(3):1-6. 3. Bourdillon KA, Delury C, Cullen B. Biofilms and delayed healing – an in vitro evaluation of silver and iodine containing dressings and their effect on bacterial and human cells. International Wound Journal 2017 Dec;14(6):1066-1075,1. Chowdhry S.A, et al. Use of oxidised regenerated cellulose/collagen dressings versus standard of care over multiple wound types: a systematic review and meta-analysis. Int Wound J. 2021. 2. Chen Y, Du P, Lv G. A meta-analysis examined the effect of oxidised regenerated cellulose/collagen dressing on the management of chronic skin wounds. Int Wound J. 2023;20(5):1544-1551. doi:10.1111/iwj.14009CHENET AL.1551 3. Snyder, R. et al. A Retrospective Study of Sequential Therapy with Advanced Wound Care Products versus Saline Gauze Dressings: Comparing Healing and Cost. Ostomy Wound Management. 2010; 56(11A):9–15. 4. Cullen B, et al. Early adoption of collagen/ORC therapies improves clinical outcome. Paper presented at: Wounds UK Harrogate, 2011. 5. Gottrup F, Cullen B, Karlsmark T, Bischoff-Mikkelsen M, Nisbet L, Gibson M. Randomized controlled trial on collagen/oxidized regenerated cellulose/silver treatment. Wound Repair & Regeneration. 2013; 21:1-10. 6. Veves A, Sheehan P, Pham HT. A randomised controlled trial of Promogran (a collagen/ oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg. 2002; 137(7):822-827. 7. Vin, F., Teot, L. and Meaume, S. (2002) The healing properties of Promogran in venous leg ulcers. J Wound Care, 11, 335-341. 8. Bourdillon KA, Delury C, Cullen B. Biofilms and delayed healing – an in vitro evaluation of silver and iodine containing dressings and their effect on bacterial and human cells. International Wound Journal. 2017. ISSN 1742-4801.Brand |
Brand
Promogran Prisma™ |
Overall Length (Imperial) |
Overall Length (Imperial)
12.6000 |
Overall Width (Metric) |
Overall Width (Metric)
1.0000 |
Overall Length (Metric) |
Overall Length (Metric)
32.0000 |
Overall Thickness (Imperial) |
Overall Thickness (Imperial)
393.7000 |
Overall Thickness (Metric) |
Overall Thickness (Metric)
1.0000 |
Overall Width (Imperial) |
Overall Width (Imperial)
0.3900 |